The relationship between vitamin D level and hepatosteatosis in obese children
- PMID: 31180389
- PMCID: PMC6526990
- DOI: 10.14744/nci.2018.26097
The relationship between vitamin D level and hepatosteatosis in obese children
Abstract
Objective: The increasing incidence of obesity in children is a significant risk factor for nonalcoholic fatty liver disease and obesity-associated morbidity. In the present study, we aimed to explore the correlation between Vitamin D level and hepatosteatosis in obese children.
Methods: A total of 110 children aged 10-16 years who presented to pediatric endocrinology outpatient clinic for obesity were enrolled. The study was completed in a single season between September and November. Hepatosteatosis was diagnosed by ultrasonography. The patients were grouped into two groups: Group 1 comprised patients with hepatosteatosis and Group 2 consisted of patients without hepatosteatosis. 25 hydroxy (25-OH) Vitamin D levels were compared between patients with and without hepatosteatosis.
Results: No statistically significant difference was observed between 25-OH Vitamin D levels of patients with and without hepatosteatosis. When the effects of age and sex were kept constant, there was no significant correlation between Vitamin D level and aspartate aminotransferase, alanine aminotransferase, and body mass index values.
Conclusion: Unlike the results of the previous studies, we were unable to detect any significant difference between Vitamin D levels of obese patients with and without hepatosteatosis. We think that obesity, rather than Vitamin D status, that is, in fact, independently associated with nonalcoholic fatty liver disease. Larger studies are needed to investigate the impact of Vitamin D in children with obesity with hepatosteatosis.
Keywords: Hepatosteatosis; Vitamin D; obese children.
Conflict of interest statement
Conflict of Interest: The authors declare no conflict of interest.
References
-
- Obesity:Preventing and Managing the Global Epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–12. 1–253. - PubMed
-
- Yıldız I, Erol OB, Toprak S, Cantez MS, Omer B, Kılıç A, et al. Role of Vitamin D in children with hepatosteatosis. J Pediatr Gastroenterol Nutr. 2014;59:106–11. - PubMed
-
- Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. Adults. Diabetes Care. 2005;28:1228–30. - PubMed
-
- Holick MF, Binkley NC, Bischoff–Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency:An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30. - PubMed
LinkOut - more resources
Full Text Sources